Metraipolis › archive › dc_d7af5b07e458

Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases — Europe PMC PMID:42279394

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279394
DOI
10.3390/cancers18111806
License (as archived)
solo-consultazione
Archived
2026-11-01T01:42:46.529Z
SHA-256 of the archived text
745d767b6c909c60e4b63567931273c24b4d4f028ed783f36b667325f73a34d2
Stable URL of this page
https://metraipolis.com/documento/dc_d7af5b07e458

How to cite

Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases — Europe PMC PMID:42279394 — Europe PMC (en), https://europepmc.org/article/MED/42279394 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7af5b07e458 (Metraipolis archive dc_d7af5b07e458, sha256 745d767b6c909c60e4b63567931273c24b4d4f028ed783f36b667325f73a34d2)
BibTeX
@misc{dcd7af5b07e458,
  title = {Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases — Europe PMC PMID:42279394},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279394},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7af5b07e458; sha256 745d767b6c909c60e4b63567931273c24b4d4f028ed783f36b667325f73a34d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279394. Agents can read the archived copy with the MCP tool read_document.